Stocks
Stonebridge Capital Acquires New Stake in Amgen Worth $1.715 Million
Stonebridge Capital Management Inc., a financial services firm, has acquired a new stake in Amgen Inc. (NASDAQ:AMGN) valued at approximately $1,715,000.
The purchase was made during the second quarter and consisted of 4,736 shares of Amgen's stock. This marks one of several recent changes to institutional holdings in AMGN, as other large investors have also increased or decreased their positions.
One such investor is Anfield Capital Management LLC, which lifted its stake in Amgen by 1,000% in the fourth quarter and now owns 77 shares worth $25,000. Dogwood Wealth Management LLC also increased its holdings in AMGN by 275% during the same period.